Medical
Advisory Board

Dr. Paul Walker is the former Director of Thoracic Oncology at East Carolina University and has been the past Program Director and Chief of Hematology/Oncology for the Brody School of Medicine as well as the Medical Director for the Clinical Trials Office. Dr. Walker has multiple medical journal publications including cancer biotherapy with breast and lung cancers. Dr. Walker has been the principal investigator on multiple clinical trials including immune therapy, immune modulating and boosting therapies. He earned his medical degree from Indiana University School of Medicine, completed his residence at Ball Memorial Hospital, and his medical oncology fellowship at the Medical College of Ohio.

Dr. Richard Lanman was most recently the Global Chief Medical Officer at Guardant Health where he planned and executed research studies, publications, and physician education in oncology genomics, which was required to obtain broad insurance coverage, incorporation in clinical guidelines, and FDA approvals and clearances. Dr. Lanman served in similar capacities as the Chief Medical Officer at cytology-based, genomics testing company Veracyte as well as at two cardiovascular, bio-diagnostics companies, diaDexus and Atherotech. Dr. Lanman graduated from Stanford with a B.S. in Chemistry before obtaining his M.D. at Northwestern University School of Medicine and completing his residency at UCSF Moffit Hospital.

Dr. James Cantrell has practiced Oncology-Hematology for over 30 years and was a co-founder and President of Alabama Oncology, LLC and Medical Director of the Bruno Cancer Center. He has published over 20 peer-reviewed articles and abstracts, and has been a member of numerous professional organizations, including the US Oncology Research Program. He earned his M.D. and completed an Internal Medicine Residency at Emory University School of Medicine, and Fellowships in Medical Oncology and Hematology at Georgetown University Hospital.